Results 181 to 190 of about 3,194,719 (204)

Use of a Keratolytic Agent With Occlusion for Topical Treatment of Hyperkeratotic Seborrheic Keratoses

SKINmed: Dermatology for the Clinician, 2008
Background . Seborrheic keratoses are the most common benign tumors in adults. Despite their negative cosmetic appearance, no topical treatment is commonly recommended for these lesions. Objective . Our objective was to assess whether clinical benefit could be achieved by using a keratolytic topical agent ...
Craig G. Burkhart, Craig N. Burkhart
semanticscholar   +5 more sources

The Effect of Keratolytic Agents on the Permeability of Three Imidazole Antimycotic Drugs Through the Human Nail

Drug Development and Industrial Pharmacy, 1998
The permeability of three imidazole antimycotics (miconazole nitrate, ketoconazole, and itraconazole) through the free edge of healthy human nail was evaluated in vitro using side-by-side diffusion cells. The influence of keratolytic substances (papain, urea, and salicylic acid) on the permeability of the antimycotics was also studied.
Quintanar-Guerrero, D, Ganem-Quintanar, A, Tapia-Olguín, P, Kalia, Yogeshvar, Buri, Pierre   +4 more
semanticscholar   +5 more sources

Photodynamic therapy of acne vulgaris using 5‐aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents

Journal of the European Academy of Dermatology and Venereology, 2010
AbstractBackground  Increasing antibiotic resistance of Propionibacterium acnes and growing awareness on the side effects of topical and systemic drugs in the treatment of acne vulgaris by physicians and patients have paved the way for a search into new efficacious and safe treatment modalities such as photodynamic therapy (PDT).
J de Leeuw, N. van der Beek, H. A. Martino Neumann, P Bjerring   +3 more
semanticscholar   +6 more sources

Development and In-vitro Characterization of Fish Oil Oleogels Containing Benzoyl Peroxide and Salicylic Acid as Keratolytic Agents

Drug Research, 2013
Topical keratolytic agents such as benzoyl peroxide (BP) and salicylic acid (SA) are one of the common treatments for inflammatory skin diseases. However, the amount of drug delivery through the skin is limited due to the stratum corneum. The purposes of this study were to investigate the ability of fish oil to act as penetration enhancer for topical ...
Mohd Hanif Zulfakar, C. M. Tan, Khurram Rehman   +2 more
semanticscholar   +5 more sources

Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid 0.5% liposomal spray and intense pulsed light in combination with topical keratolytic agents

Yearbook of Dermatology and Dermatologic Surgery, 2011
George M. Martin
semanticscholar   +4 more sources

Onychomycosis Treated with Itraconazole or Griseofulvin Alone with and without a Topical Antimycotic or Keratolytic Agent

International Journal of Dermatology, 1991
Abstract: An open, comparative, randomized study was conducted using griseofulvin or itraconazole for the treatment of onychomycosis of the foot. Group I (45 patients) received itraconazole and Group II (45 patients) received griseofulvin. Each group was divided into three subgroups that received different topical treatment: antimycotic cream ...
Fernández G, Domínguez L, Arenas R
openaire   +4 more sources

Effect of Metamorphed Keratolytic Agent on the Behavior of Imiquimod Loaded Hybrid Vesicles Containing Gel

Journal of Pharmaceutical Sciences, 2019
The cost, side effects, and patient compliance-related issues of topically effective imiquimod have prevented its widespread acceptance. The present work intends to evaluate the feasibility of overcoming the shortcomings of poorly soluble and skin-penetrating immunomodulator by using biocompatible keratolytic agent with drug-loaded hybrid vesicles ...
Gajanand Sharma, Mandeep Sharma, Om Prakash Katare, Kaisar Raza, Bhupinder Singh   +4 more
openaire   +4 more sources

Evaluation of a urea/lactic acid-based topical keratolytic agent (ULABTKA) for prevention of capecitabine-induced hand and foot syndrome (HFS): NCCTG trial N05C5.

Journal of Clinical Oncology, 2010
9017 Background: HFS is a dose-limiting toxicity of capecitabine, occurring in 43-71% of patients. No effective preventative treatment has been definitively demonstrated.
John W. Kugler, Daniel Satele, Sherry L. Wolf, C. L. Loprinzi, D. Christian, Kendrith M. Rowland, R. Qin, Patrick J. Flynn, Jeffrey L. Berenberg, Smitha Menon   +9 more
openaire   +3 more sources

[Salicylic acid as a keratolytic agent].

Annales de dermatologie et de venereologie, 2002
J.-C. Béani
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Keratosis pilaris: an update and approach to management.

Italian journal of dermatology and venereology, 2023
Keratosis pilaris (KP) is a common, hyperkeratotic skin condition characterized by small, folliculocentric papules with variable perifollicular erythema.
N. Kodali, Viral M. Patel, R. Schwartz
semanticscholar   +1 more source